ANG Lifesciences India Limited announced that it expects to receive INR 60.5 million in funding from ANG Capital Investments Private Limited

ANG Lifesciences India Limited announced a private placement of 2,200,000 fully convertible warrants at issue price of INR 27.5 per warrant for gross proceeds of INR 60,500,000 on April 5, 2023. The warrants are going to be convertible into common shares of the company at an exercise price of INR 82.5 per share for a period of 18 months from the date of closing. The warrants are issued on the preferential basis.

The transaction will include participation from returning investor ANG Capital Investments Private Limited. The transaction has been approved by the board of directors of the company.